Likewise, a more recent study has shown that TRIM16 attenuates hepatocyte steatosis and inflammation in a mouse NASH model by directly interacting with the phosphorylated form of TAK1 and promoting its degradation, leading to suppressed NASH development (16). The gene discussed is TRIM16; the disease is metabolic dysfunction-associated steatohepatitis.